APM - Aptorum Group Limited
NASDAQ
->
Healthcare
->
Biotechnology
London,
United Kingdom
Type: Equity
APM price evolution
APM
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jul 2023 | 31 Mar 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2.01 | $2.01 | $0.34 | $0.34 |
| Short term investments | ||||
| Net receivables | $0.07 | $0.07 | $0.71 | $0.69 |
| Inventory | ||||
| Total current assets | $2.48 | $2.48 | $1.9 | $1.9 |
| Long term investments | $16.1 | $16.1 | $9.74 | $9.74 |
| Property, plant & equipment | $1.85 | $1.85 | $2.5 | $2.5 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | ||||
| Total investments | ||||
| Total assets | $20.64 | $20.64 | $14.41 | $14.41 |
| Current liabilities | ||||
| Accounts payable | $0.02 | $0.02 | $0.48 | $0.01 |
| Deferred revenue | ||||
| Short long term debt | $0.13 | $0.13 | $0.3 | $0.3 |
| Total current liabilities | $2.1 | $2.1 | $1.43 | $1.43 |
| Long term debt | $3.06 | |||
| Total noncurrent liabilities | ||||
| Total debt | ||||
| Total liabilities | $5.26 | $5.26 | -$7.43 | $1.63 |
| Shareholders' equity | ||||
| Retained earnings | -$68.16 | -$68.16 | -$70.82 | -$70.82 |
| Other shareholder equity | -$9.47 | -$9.47 | $0.03 | -$9.04 |
| Total shareholder equity | $15.38 | $15.38 | $12.78 | $12.78 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $2.01 | $1.88 | $8.13 | $3.5 |
| Short term investments | $0.1 | $0.24 | $28.39 | |
| Net receivables | $0.07 | $1.39 | $3.63 | $0.34 |
| Inventory | $0.03 | $0.04 | $0.04 | |
| Total current assets | $2.48 | $7.07 | $12.69 | $33.66 |
| Long term investments | $16.1 | $9.74 | $4.16 | $4.08 |
| Property, plant & equipment | $1.85 | $3.17 | $3.89 | $5.23 |
| Goodwill & intangible assets | ||||
| Total noncurrent assets | $10.57 | |||
| Total investments | ||||
| Total assets | $20.64 | $20.87 | $21.91 | $44.23 |
| Current liabilities | ||||
| Accounts payable | $0.02 | $0.12 | $0.69 | $0.94 |
| Deferred revenue | ||||
| Short long term debt | $0.13 | $6.32 | $0.06 | $0.2 |
| Total current liabilities | $2.1 | $12.5 | $4.38 | $3.87 |
| Long term debt | $3.06 | $0.5 | $2.06 | |
| Total noncurrent liabilities | $2.21 | |||
| Total debt | ||||
| Total liabilities | $5.26 | $13.03 | -$1.7 | $2.4 |
| Shareholders' equity | ||||
| Retained earnings | -$68.16 | -$65.34 | -$55.54 | -$30.49 |
| Other shareholder equity | -$9.47 | -$7.84 | -$0 | $0.05 |
| Total shareholder equity | $15.38 | $7.83 | $23.61 | $41.83 |
| (in millions $) | 31 Jan 2024 | 30 Jul 2023 | 31 Mar 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.43 | $0.22 | $0.38 | |
| Cost of revenue | $0.21 | $0.34 | ||
| Gross Profit | $0.01 | $0.01 | $0 | $0.04 |
| Operating activities | ||||
| Research & development | $1.61 | $2.36 | ||
| Selling, general & administrative | $1.5 | $2.18 | ||
| Total operating expenses | $4.19 | $5.82 | $3.49 | $4.91 |
| Operating income | -$3.27 | -$4.53 | ||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | $6.33 | -$0.1 | -$0.05 | -$0 |
| Net income | ||||
| Net income | $2.66 | -$5.49 | -$2.74 | -$3.96 |
| Income (for common shares) | -$2.74 | -$3.96 | ||
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $0.43 | $1.3 | $1.54 | $0.91 |
| Cost of revenue | $0.42 | $1.22 | $1.46 | $1.02 |
| Gross Profit | $0.01 | $0.08 | $0.08 | -$0.1 |
| Operating activities | ||||
| Research & development | $5.2 | $9.22 | $9.91 | $10.4 |
| Selling, general & administrative | $4.47 | $8.11 | $7.8 | $7.36 |
| Total operating expenses | $11.16 | $18.81 | $20.75 | $21.19 |
| Operating income | -$10.72 | -$17.51 | -$19.21 | -$20.28 |
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | ||||
| Interest expense | -$0.12 | $0.24 | ||
| Net income | ||||
| Net income | -$2.82 | -$9.8 | -$25.05 | $7.07 |
| Income (for common shares) | -$2.82 | -$9.8 | -$25.05 | $6.31 |
| (in millions $) | 31 Dec 2023 | 30 Sep 2023 | 30 Jul 2023 | 31 Dec 2022 |
|---|---|---|---|---|
| Net income | $1.33 | $1.33 | -$3.96 | |
| Operating activities | ||||
| Depreciation | $0.18 | $0.18 | $0.26 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$0.77 | -$0.77 | -$2.7 | |
| Investing activities | ||||
| Capital expenditures | -$0.02 | |||
| Investments | ||||
| Total cash flows from investing | $0.03 | $0.03 | $0.56 | -$0.13 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $0.01 | |||
| Net borrowings | $1.5 | $1.5 | $1.74 | |
| Total cash flows from financing | $1.5 | $1.5 | $1.09 | $1.74 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | $0.77 | $0.77 | -$4.54 | -$1.09 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$2.82 | -$9.8 | -$27.11 | $4.92 |
| Operating activities | ||||
| Depreciation | $1.04 | $1.09 | $1.19 | $1.33 |
| Business acquisitions & disposals | ||||
| Stock-based compensation | ||||
| Total cash flows from operations | -$7.72 | -$12.32 | -$14.65 | -$15.93 |
| Investing activities | ||||
| Capital expenditures | -$0 | -$0.19 | -$0.14 | -$0.16 |
| Investments | ||||
| Total cash flows from investing | $0.63 | $2.44 | $16.51 | $1.84 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $1.59 | $0.17 | $4.82 | $17.5 |
| Net borrowings | $2.5 | $6.45 | -$2.04 | -$4.36 |
| Total cash flows from financing | $4.09 | $6.63 | $2.78 | $12.42 |
| Effect of exchange rate | ||||
| Change in cash and equivalents | -$3.01 | -$3.25 | $4.64 | -$1.67 |
News
Fundamentals
| Market cap | $7.77M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 5.18M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | -$9.52M |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | -0.82 |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | 0.31 |
| Book/Share | 4.80 |
| Cash/Share | 0.39 |
| EPS | -$1.84 |
|---|---|
| ROA | -54.35% |
| ROE | -67.65% |
| Debt/Equity | 0.34 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.18 |
| Quick ratio | N/A |